MTOR and breast carcinoma: During the progression of endocrine resistance, following long‐term estrogen deprivation, PI3K primarily activates the mTOR substrate p70 ribosomal protein S6 kinase (p70S6K) in the human breast cancer cell lines MCF‐7 and MDA‐MB‐361 [4].